Advertisement

Topics

Immune Pharma starts enrolment in Phase I/II trial of Ceplene for CMML

19:00 EDT 21 Jun 2017 | Net Resources International

Immune Pharmaceuticals has started patient recruitment for Phase I/II clinical trial of Ceplene (histamine dihydrochloride) to treat chronic myelomonocytic leukaemia (CMML) patients. 

Original Article: Immune Pharma starts enrolment in Phase I/II trial of Ceplene for CMML

NEXT ARTICLE

More From BioPortfolio on "Immune Pharma starts enrolment in Phase I/II trial of Ceplene for CMML"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...